Emma Helstrom
Papers
7
Total Citations
54
H-Index
5
About
Dr. Emma Helstrom is a leading urologic oncologist whose research focuses on optimizing surgical and oncological outcomes for upper tract urothelial carcinoma (UTUC). As a principal investigator within the ROBUUST 2.0 collaborative group, she has spearheaded landmark studies analyzing robot-assisted nephroureterectomy (RANU) in over 1,100 patients, demonstrating its safety and mid-term efficacy. Her work has critically evaluated the impact of bladder cuff excision techniques, the role of neoadjuvant chemotherapy in locally advanced disease, and the prognostic utility of diagnostic ureteroscopy—challenging guideline variability and refining risk stratification. Dr. Helstrom also developed a novel pretreatment nomogram to predict muscle invasion, directly influencing treatment selection. Her comparative analysis of robotic distal ureterectomy for high-risk distal tumors has advanced kidney-sparing surgery in controversial settings. With her most-cited papers accumulating over 50 citations within just two years, Dr. Helstrom’s contributions are rapidly shaping evidence-based practice in UTUC management, offering clearer pathways for surgical decision-making and personalized oncologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7